Thus, the lack of effect of GRK5-IN-2 on adipose inflammatory genes distinguishes it from Amlexanox, which exerts anti-inflammatory effects and attenuates diet-induced obesity. This evidence concerns the gene GRK5 and obesity due to melanocortin 4 receptor deficiency.